Latest Health News
Beyfortus RSV Vaccine Shows Long-Term Protection Into Second Season
A study published in The Lancet Infectious Diseases demonstrates that infants immunized with Beyfortus (nirsevimab) during their first RSV season experienced statistically significant reductions in RSV-related hospitalizations during their second season, with a 78.2% reduction in rehospitalizations among previously hospitalized infants.
Scientists Identify Key Enzyme Driving Cancer's Genetic Chaos
Researchers at UC San Diego discovered that the enzyme N4BP2 triggers chromothripsis, a catastrophic chromosome-shattering event occurring in approximately one in four cancers. Blocking this enzyme dramatically reduced genomic destruction in cancer cells, offering a new therapeutic intervention point to slow cancer evolution and drug resistance.
FDA Approves Optune Combined With Chemotherapy for Pancreatic Cancer
The U.S. Food and Drug Administration approved tumor-treating fields (Optune) combined with chemotherapy for pancreatic cancer, representing a significant expansion of device-based oncology treatment options.
Measles Cases Continue Spreading Across Multiple U.S. States
ProMED alerts report ongoing measles outbreaks in the United States, with new cases confirmed in South Carolina, Florida, North Carolina, and New Jersey as of mid-February 2026.
Pertussis Outbreak Affects Nebraska Infants
Increased pertussis cases among infants in Nebraska were reported, according to ProMED surveillance data from February 13, 2026.
Cholera Cases Rising in Mozambique With Fatalities
Fatal cholera cases with increasing transmission were documented in Mozambique, highlighting ongoing disease threats in the region.
Lassa Fever Outbreak Confirmed in Nigeria
ProMED reported a Lassa fever outbreak in Benue State, Nigeria, marking the ninth alert for this hemorrhagic fever outbreak.
Pembrolizumab Use Expands in Oncology Treatment
The FDA broadened indications for the immunotherapy drug pembrolizumab across multiple cancer types and treatment lines, reinforcing immunotherapy's dominant role in modern oncology.
PATINA Trial Shows Palbociclib Benefits in Breast Cancer
The PATINA trial demonstrated meaningful improvements in progression-free survival with palbociclib in patients with advanced hormone receptor–positive breast cancer.
Centivax Initiates Phase 1 Trial for Universal Flu Vaccine
Centivax, Inc., a clinical-stage biotechnology company, initiated a Phase 1 first-in-human clinical trial for a universal influenza vaccine, advancing efforts to develop broader protection against multiple flu strains.
Lilly's Retevmo Shows Benefit as Adjuvant Therapy for Lung Cancer
Eli Lilly announced positive topline results from the Phase 3 LIBRETTO-432 trial, demonstrating that Retevmo (selpercatinib) delivers substantial event-free survival benefit as an adjuvant therapy in early-stage RET fusion-positive lung cancer.